Head-to-head
Found vs Eden
Found and Eden both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
Found
Ranked #3 · Grade B+
Best for: Parents who want low, identical pricing on either molecule and don't mind a coaching-subscription wrapper around the medication.
Visit FoundEden
Higher scoreRanked #2 · Grade B+
Best for: Parents who want a transparent, well-run async program with both molecules and don't mind paying above the cheapest tiers for a tidy experience.
Visit EdenThe verdict
Eden edges out Found on the Rx-Readiness Score, 89 to 88 (B+ vs B+). Parents who want a transparent, well-run async program with both molecules and don't mind paying above the cheapest tiers for a tidy experience.
Found is still a genuine option — identical low pricing on both molecules plus built-in coaching — the flat-fee simplicity is a real time-saver if you also want a little accountability. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Found | Eden |
|---|---|---|
| Rx-Readiness Score | 88/100 · B+ | 89/100 · B+ |
| Overall rank | #3 | #2 |
| Semaglutide | $129/mo | $239/mo |
| Tirzepatide | $129/mo | $349/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Found
Ranked #3 · Grade B+
What we like
- Low, identical flat pricing on both molecules — switching costs you nothing
- Coaching baked in, useful if you want structure without booking a separate service
- Nationwide, with a mostly async onboarding flow
The caveats
- The coaching-subscription model isn't for everyone
- Compounded only — no brand or oral option
- Support cadence can feel program-driven rather than on-demand
Eden
Ranked #2 · Grade B+
What we like
- Clear flat pricing and a straightforward async signup — no drawn-out scheduling
- Both semaglutide and tirzepatide, available in all 50 states
- Strong up-front disclosure, so there are fewer surprises after you commit
The caveats
- Premium sticker price versus the budget tiers
- Compounded only — no brand-name lane
- No oral route for the needle-averse
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Found and Eden against other providers on our shortlist.
Or browse the full comparison hub.